Loading clinical trials...

Phase II Evaluation of AHCC for the Eradication of HPV Infections | Clinical Trials | Clareo Health

COMPLETEDNANCT02405533

Phase II Evaluation of AHCC for the Eradication of HPV Infections

This is a phase II randomized, double-blind placebo-controlled, crossover trial. The primary outcome of this trial is achieving durable eradication persistent high risk HPV infection determined by HPV...

Lead sponsor: The University of Texas Health Science Center, Houston•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITINGPhase 2

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

NCT05564390 · Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm, and more

RECRUITINGPhase 2/3

Can PLIA Reduce Early Post-operative Pain After PAO Surgery?

NCT06519955 · Hip Dysplasia

RECRUITINGPhase 2

Oral Bevacizumab-800CW and Cetuximab-800CW Administration to Detect Early Esophageal Adenocarcinomas

NCT05745857 · Barrett's Esophagus Without Dysplasia, Barrett Oesophagitis With Dysplasia, and more

RECRUITINGPhase 2

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

NCT05735717 · Hematologic Malignancy, Acute Leukemia, and more

RECRUITINGPhase 2

Developing a First-void Urine-based Infection Model to Study HPV-specific Antibody-virion Interaction Before and After HPV Vaccination

NCT07407569 · Human Papilloma Virus Infection Type 16

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 20, 2021Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment50

Start dateApr 2015

Last updatedJan 20, 2021

Condition

Human Papilloma Virus Dysplasia CIN1 CIN2

Locations shown

UTHealth Medical School at Houston

Houston, Texas

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 20, 2021Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Phase II Evaluation of AHCC for the Eradication of HPV Infections

What this study is about

Clareo turns complex medical information into clear understanding you can use.

Sponsors

Related studies

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Can PLIA Reduce Early Post-operative Pain After PAO Surgery?

Oral Bevacizumab-800CW and Cetuximab-800CW Administration to Detect Early Esophageal Adenocarcinomas

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

Developing a First-void Urine-based Infection Model to Study HPV-specific Antibody-virion Interaction Before and After HPV Vaccination

Trial snapshot

Condition

Locations shown

For caregivers